Table 3.

Cases of cardio-cerebrovascular events caused by stanozolol

Ref.	Biographical information	Drug and dose	Duration of use	Diagnosis	Coronary artery (by CAG or autopsy)	Therapy	Prognosis
[16]	30-year-old male	Orally stanozolol 10 mg daily and intramuscularly 250 mg testosterone twice per week	2 mo	Anterior wall AMI	LAD	Medical treatment	Discharged
[17]	25-year-old male	Nandrolone 100 mg/wk stanozolol tablets 25 mg/d	3 wk	Takotsubo cardiomyopathy	N	Medical treatment	Discharged
[18]	26-year-old male	Stanozolol 10 mg daily	3 mo	Ischemic Stroke	N (Angiography of the Cerebral artery)	Medical treatment and rehabilitation	Discharged with severe disability
[19]	28-year-old male	Stanozolol 280mg weekly	2 yr	NSTEMI; ventricular tachycardia	LADRCA	Percutaneous translumind coronary angioplasty	Discharged
[20]	22-year-old male	Stanozolol, 10 mg/d and clenbuterol 40 μg/d for 7 dstanozolol, 20 mg/d and clenbuterol 80 μg/d for 3 d. triiodothy-ronine 25ug/d	10 d	Cardiomyopathy; acute hepatic injury	NS	Medical treatment	Discharged
[21]	29-year-old female	Ephedrine, tadalafil, metandienon, mestanolon, stanozolol	NS	Sudden cardiac death; cardiac arrhythmia	LAD	NA	Sudden cardiac death
[22]	24-year-old male	Stanozolol, testosterone, tamoxifen, mesterolone, and nandrolone	6 mo	Cardiorespiratoryarrest	The left main trunk and LAD	NA	Sudden cardiac death
[23]	24-year-old male	Stanozolol (40 mgs daily) nandrolone 200 mgs intramuscularly twice weekly, Sustanon 250 (testosterone esters) 1 mL intramuscularly once a week	6 wk	Anterior wall AMI	NS	Medical treatment	NS
[24]	37-year-old male	Nandrolone Testosterone cypionate stanozolol; oxandrolone	3-16 wk	Inferior wall AMI	N; Consider spasm	Medical treatment	Discharged

CAG: Coronary angiography; N: Normal; LAD: Left descending coronary; AMI: Acute myocardial infarction; RCA: Right Coronary Artery; NA: Not applicable; NS: Not Described.